一项随机对照试验:研究预测列线图在IVF/ICSI周期中选择FSH起始剂量的应用
该随机对照试验比较了基于多生物标志物(年龄、第3天FSH、抗苗勒管激素)的列线图与基于年龄的策略选择FSH起始剂量的效率。主要结局为获卵数8-14枚的最佳反应比例。列线图组最佳反应比例为63%(58/92),对照组为42%(42/99),差异+21%(95%CI 0.07-0.35,P=0.0037)。临床妊娠率和每患者冷冻胚胎数无显著差异。
要点
- 列线图组最佳获卵数(8-14枚)比例63%,显著高于年龄组的42%(P=0.0037)。
- 临床妊娠率和每患者冷冻胚胎数在两组间无显著差异。
- 作者建议开展大型试验研究对活产率的可能影响。
核心结论
- 根据卵巢储备选择FSH起始剂量与最佳反应患者比例增加相关;建议开展大型试验研究对活产率的可能影响。
研究设计与样本
- 随机对照试验,191例首次IVF/ICSI周期患者,采用长方案促性腺激素释放激素激动剂方案,随机分为列线图组和年龄组。
主要发现
- 最佳反应(获卵数8-14枚)在列线图组为58/92(63%),在对照组为42/99(42%),差异+21%(95%CI 0.07-0.35,P=0.0037)。
- 临床妊娠率无显著差异。
- 每患者冷冻胚胎数无显著差异。
关键数值与推荐
- 年龄组起始剂量:≤35岁为150 IU,>35岁为225 IU。
- 列线图组起始剂量基于年龄、第3天FSH和抗苗勒管激素。
临床怎么用
- 作者建议开展大型试验研究根据卵巢储备选择FSH起始剂量对活产率的可能影响。
局限性
- 作者建议开展大型试验研究对活产率的可能影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The number of oocytes retrieved is a relevant intermediate outcome in women undergoing IVF/intracytoplasmic sperm injection (ICSI). This trial compared the efficiency of the selection of the FSH starting dose according to a nomogram based on multiple biomarkers (age, day 3 FSH, anti-Müllerian hormone) versus an age-based strategy. The primary outcome measure was the proportion of women with an optimal number of retrieved oocytes defined as 8-14. At their first IVF/ICSI cycle, 191 patients underwent a long gonadotrophin-releasing hormone agonist protocol and were randomized to receive a starting dose of recombinant (human) FSH, based on their age (150 IU if ≤35 years, 225 IU if >35 years) or based on the nomogram. Optimal response was observed in 58/92 patients (63%) in the nomogram group and in 42/99 (42%) in the control group (+21%, 95% CI = 0.07 to 0.35, P = 0.0037). No significant differences were found in the clinical pregnancy rate or the number of embryos cryopreserved per patient. The study showed that the FSH starting dose selected according to ovarian reserve is associated with an increase in the proportion of patients with an optimal response: large trials are recommended to investigate any possible effect on the live-birth rate.
引用
- Allegra A, Marino A, Volpes A, et al. A randomized controlled trial investigating the use of a predictive nomogram for the selection of the FSH starting dose in IVF/ICSI cycles. Reprod Biomed Online. 2017. PMID: 28189417. doi:10.1016/j.rbmo.2017.01.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。